# THIOTEPA
> **ANDA217559** · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2024-08-20
## Drug
- **FDA Application Number:** ANDA217559
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** THIOTEPA
- **Generic name:** Thiotepa
- **Active ingredients:** THIOTEPA
- **Dosage form:** POWDER
- **Route:** INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
- **Marketing status:** Prescription
- **Sponsor:** REGCON HOLDINGS
- **First approval:** 2024-08-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217559)
---
*MORVS · CC0 1.0*